Bioventus Inc. Class A Common Stock (BVS)
Bioventus Inc. Class A (BVS) is a global leader in orthobiologic solutions dedicated to helping patients recover faster from injuries and surgeries. The company develops and commercializes innovative therapies in areas such as bone healing, joint health, and pain management, with a focus on bone graft substitutes, bioactive solutions, and regenerative products to improve patient outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 31, 2004 | $0.61 | 2004-03-26 | 2004-03-30 |
| December 31, 2003 | $0.61 | 2003-12-26 | 2003-12-30 |
Dividends Summary
- Bioventus Inc. Class A Common Stock has issued 2 dividend payments over the past 1 years
- The most recent dividend was paid 7843 days ago, on March 31, 2004
- The highest dividend payed out to investors during this period was $0.61 per share
- The average dividend paid during this period was $0.61 per share.
Company News
Bioventus secured a new $400 million credit agreement, replacing its previous 2019 credit facilities, which reduces interest expenses and increases liquidity from $40 million to $100 million in revolving credit.
The article discusses how September has historically been a weak month for the stock market, but this year the S&P 500, Dow, and Nasdaq have gained over 1% so far, breaking a 5-year trend. The author recommends buying three breakout stocks that could take advantage of the broader market's upward movement: Bioventus (BVS), Great Lakes Dredge & Dock (GLDD), and AxoGen (AXGN).
Merck (MRK) exercises the option that will convert the collaboration deal with partner Orion for prostate cancer candidate opevesostat into a license agreement.
Penny stocks to buy according to these insiders this month. The post 10 Top Penny Stocks To Buy According To Insiders In August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The company's reduced guidance concerned investors.